Products

Ghost Overlay AI

AI-native

Your invisible AI assistant for meetings, interviews, and presentations.

ghostoverlay-ai.com Productivity & Collaboration / Meetings & Note-Takers

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Akshat Singh panwar
@ghosttourlabs
Launched
9mo ago
2026-02-13 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions

  • Launched on Product HuntLaunch

    Undetectable. Unstoppable. Your edge in every live meeting.

    Feb 13 · 9mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct40%
  • Organic Search32%
  • Referrals10%
  • Social6%
  • Other12%

Countries

  • India89%
  • Germany11%

Search

Domain authority —Domain registered 2026-02-09

KeywordMonthly volume
ghostly ai3,100
ghotly ai460
invisble ai overlay150
notemotion ai alt90
ai assistant overlay window—

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-03 · Source page

Pages & changes

Tracked since 2026-02-13

Key pages

Weekly snapshots
ghostoverlay-ai.com/ Snapshot 2026-11-03

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Ghost Overlay AI get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Ghost Overlay AI and what platforms does it support?
Ghost Overlay AI is catalogued under Meetings & Note-Takers: Your invisible AI assistant for meetings, interviews, and presentations.. Supported platforms: Web.

Related products in this category

Productivity & Collaboration / Meetings & Note-Takers

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.